2026-01-02 - Analysis Report
Okay, here's a breakdown of the Tempus AI (TEM) stock information, incorporating simple numbers, analysis, and relevant news headlines:

**0. Introduction**

This report analyzes Tempus AI Inc. (TEM) and compares its performance against the S&P 500 (VOO). We will look at return rates, market indicators, recent news, and analyst opinions to provide a comprehensive overview.

**1. Return Rate Comparison**

*   **TEM Cumulative Return:** 5.46%
*   **VOO (S&P 500) Cumulative Return:** 30.53%
*   **Divergence:** -25.1 (Current), -40.6 (Min), 74.4 (Max), 13.5 (Relative Divergence)

**Analysis:** Tempus AI has significantly underperformed the S&P 500 over the observed period. The divergence is negative, meaning TEM has lower cumulative return compared to the S&P 500.  The relative divergence of 13.5 indicates that the current divergence is closer to its historical minimum than its historical maximum.

*   **Company Overview:** Tempus AI Inc. is a technology company focused on precision medicine through data and artificial intelligence.

**Alpha, Beta Analysis:**

|            | CAGR    | MDD     | Alpha   | Beta  | Cap(B) |
|------------|---------|---------|---------|-------|--------|
| 2023-2025  | 69.0%   | 76.7%   | 43.0%   | 2.8   | 10.5   |

**Analysis:**

*   **CAGR (Compound Annual Growth Rate):** 69.0% indicates a high growth rate over the 2023-2025 period.
*   **MDD (Maximum Drawdown):** 76.7% signifies a substantial potential loss from peak to trough, indicating high volatility and risk.
*   **Alpha:** 43.0% represents the excess return compared to a benchmark index (likely the S&P 500). A positive Alpha suggests that Tempus AI has outperformed its benchmark on a risk-adjusted basis.
*   **Beta:** 2.8 indicates that Tempus AI is significantly more volatile than the market. It is 2.8 times more sensitive to market movements than the S&P 500.
*   **Cap (B):** 10.5 indicates a market capitalization of $10.5 billion.

**2. Recent Stock Price Fluctuations**

*   **Current Close:** $59.05
*   **Previous Close:** $60.39
*   **Change:** -$2.22 (-2.22%)
*   **5-day SMA:** $61.57
*   **20-day SMA:** $68.35
*   **60-day SMA:** $77.41

**Analysis:** The stock price is currently below all three moving averages (5-day, 20-day, and 60-day SMA), suggesting a downtrend. The negative change from the previous close also confirms this.

**3. Market Indicators**

*   **MRI (Market Risk Indicator):** 0.9 (Medium Investment Recommended)
*   **RSI (Relative Strength Index):** 15.83 (Oversold)
*   **PPO (Percentage Price Oscillator):** -1.09 (Negative)
*   **Hybrid Signal:** Buy 100% of cash (14 shares - Very Safe - MRI:0.90). Monthly invest 5.0% of total investment ($1,000.00)
*   **Recent (20 days) Relative Divergence Change:** -7.3 (Negative trend)
*   **Expected Return (%):** 0.0%

**Analysis:**

*   **MRI:** While the MRI suggests medium investment, other indicators paint a more cautious picture.
*   **RSI:** The RSI is significantly below 30, indicating an oversold condition, which *could* suggest a potential for a rebound.
*   **PPO:** The negative PPO confirms the downtrend.
*   **Hybrid Signal:** Suggests a buying opportunity, albeit with a small initial investment.
*   **Divergence Change:** The recent negative change in relative divergence reinforces the short-term downward trend.
*   **Expected Return:** The 0.0% expected return compared to S&P 500 is unpromising.

**4. Recent News & Significant Events**

*   **Positive AI Integration:**  "3 MedTech Stocks Poised to Gain in 2026 From the AI Boom" and "This AI Health Stock is Up Over 150% This Year—and It’s Not Slowing Down" suggest long-term potential due to AI advancements in the healthcare sector.
*   **Transition and Performance Concerns:** "Is TEM Stock a Buy, Hold, or Sell During Its Pivotal Transition?" and "$TEM stock fell 8% this week. Here's what we see in our data." indicate concerns about the company's current state and recent performance.
*   **Analyst Downgrade:** "JPMorgan Chase & Co. Has Lowered Expectations for Tempus AI (NASDAQ:TEM) Stock Price" is a negative signal that could further depress the stock price.

**4-2. Analyst Opinions**

*   **Consensus:** Buy (Mean: 2.14)
*   **Opinions:** 12 Analysts
*   **Target Price:** Average: $88.92, High: $105.00, Low: $80.00
*   **Recent Rating Changes:** No rating changes available.

**Analysis:** Analyst consensus is "Buy" with a significant upside potential implied by the target prices. However, recent news of JPMorgan Chase lowering expectations needs to be considered.

**5. Comprehensive Analysis**

Tempus AI (TEM) is a company operating in the high-growth but volatile field of AI-driven precision medicine.  While the company exhibits high growth (CAGR of 69%) and a positive Alpha, it also carries significant risk, demonstrated by its high Beta, large Maximum Drawdown (MDD), negative recent return and underperformance compared to S&P 500.

Recent news is mixed. Positive articles highlight the potential of AI in medtech. However, articles about a stock price decline and JPMorgan Chase lowering expectations are concerning.

Technically, the stock is in a downtrend, trading below key moving averages and with an oversold RSI. The hybrid signal suggests a limited buying opportunity.

**Overall Recommendation:**

While analysts have a consensus "Buy" rating and believe the company has long-term potential, the recent negative performance, analyst downgrade, significant volatility, and underperformance compared to S&P 500 raise concerns.  The high risk and recent negative trends suggest a cautious approach is warranted. Before investing, investors should carefully weigh the potential benefits against the substantial risks. Further research and monitoring of the company's progress are crucial.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.